Literature DB >> 6125195

Beta-adrenoceptor blockade in stress due to oral surgery.

B Brisse, P Tetsch, W Jacobs, F Bender.   

Abstract

1 The effects of a single oral dose of 5 mg pindolol (P) and 100 mg metoprolol (M) were assessed in a double-blind study in 30 patients undergoing oral surgery. 2 Systolic and diastolic blood pressures and heart rate were reduced 90 min after oral medication and did not exceed initial values at rest during the procedure. 3 Noradrenaline, adrenaline and c-AMP concentrations did not differ at any time from the control values at rest after P, but were increased after local anaesthesia and during oral surgery after M as were the metabolic responses reflected by plasma concentrations of glucose and free-fatty acids. 4 Plasma levels of ACTH and cortisol showed the typical increase during the procedure, being independent of beta-adrenoceptor blockade. In contrast to the cardioselective antagonist M, prophylactic administration of the non-selective drug P prevented the sympathetic and metabolic responses to the stress of oral surgery. 5 Hypothalamic and adrenal stimulation were not reduced by either selective or non-selective beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125195      PMCID: PMC1402143          DOI: 10.1111/j.1365-2125.1982.tb01950.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

2.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

3.  A simplified radiometric assay for plasma norepinephrine and epinephrine.

Authors:  P G Passon; J D Peuler
Journal:  Anal Biochem       Date:  1973-02       Impact factor: 3.365

4.  [Experience with a colorimetric method for the determination of nonesterified fatty acids in serum].

Authors:  P Dieterle; C Wülfert-Heldrich; J Henner; K Schwarz
Journal:  Z Klin Chem Klin Biochem       Date:  1968-05

5.  [The use of beta-receptor blocking agents for the prevention of hazards of local anesthesia].

Authors:  E Machtens; K Opitz
Journal:  Dtsch Zahnarztl Z       Date:  1967-02

Review 6.  beta Adrenergic blocking drugs.

Authors:  B N Prichard; C W Owens
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

7.  Neural and psychologic mechanisms and the problem of sudden cardiac death.

Authors:  B Lown; R L Verrier; S H Rabinowitz
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

8.  [Clinical study on stress protective action of cloxazolam in jaw surgery in double blind comparison to placebo (author's transl)].

Authors:  B Brisse; P Tetsch; A Toye
Journal:  Arzneimittelforschung       Date:  1980

9.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

  9 in total
  2 in total

1.  Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.

Authors:  J Trap-Jensen; J E Carlsen; O J Hartling; T L Svendsen; M Tangø; N J Christensen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  Taking diabetes to heart--deregulation of myocardial lipid metabolism in diabetic cardiomyopathy.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.